113 related articles for article (PubMed ID: 5805647)
1. [Development of immunobiological indicators in children with hyperbilirubinemia].
Nejedlá Z
Cesk Pediatr; 1969 Jul; 24(7):577-83. PubMed ID: 5805647
[No Abstract] [Full Text] [Related]
2. [Immunological maturation of children suffering from intrauterine dystrophy syndrome].
Kobielowa Z; Miecznikowska M; Pietrzyk J; Michalik R; Konik R
Pol Tyg Lek; 1974 Nov; 29(46):1969-72. PubMed ID: 4431743
[No Abstract] [Full Text] [Related]
3. Serum immunoglobulin patterns in the first year of life in normal and low birth weight infants. I. Relationship to birth weight.
Lewis CJ; Stevens LH; Wells JV
Med J Aust; 1973 Feb; 1(6):282-8. PubMed ID: 4693218
[No Abstract] [Full Text] [Related]
4. Factors affecting the development of serum immunoglobulin levels in infants.
Vlahović V; Rede T; Beleznay O; Pavĕsić D; Racki V
Pediatrics; 1973 Aug; 52(2):206-12. PubMed ID: 4737245
[No Abstract] [Full Text] [Related]
5. Immunoglobulins G and M in newborn cord serum.
Szabo MA; Segal S; Ross LM
Isr J Med Sci; 1974 Jul; 10(7):738-42. PubMed ID: 4212072
[No Abstract] [Full Text] [Related]
6. [Isoimmunization in pediatrics].
Kacprzak-Bergman I
Pediatr Pol; 1975 Jul; 50(7):933-7. PubMed ID: 1143968
[No Abstract] [Full Text] [Related]
7. [ABO compatibility and isoimmune neonatal thrombopenia].
Gratwohl AA; Shulman NR
Schweiz Med Wochenschr; 1977 Oct; 107(41):1464. PubMed ID: 918600
[TBL] [Abstract][Full Text] [Related]
8. Prevention of hyperbilirubinemia of prematurity by phototherapy.
Lucey J; Ferriero M; Hewitt J
Pediatrics; 1968 Jun; 41(6):1047-54. PubMed ID: 5652916
[No Abstract] [Full Text] [Related]
9. The development of immunological factors in infants with hyperbilirubinemia.
Nejedlá Z
Pediatrics; 1970 Jan; 45(1):102-4. PubMed ID: 5410230
[No Abstract] [Full Text] [Related]
10. Pregnancy as an experimental system for the study of immunological diseases.
Scott JS
J Reprod Fertil Suppl; 1968 Apr; 3():Suppl 3:41-8. PubMed ID: 4941778
[No Abstract] [Full Text] [Related]
11. [Interrelationship of the physical development of newborn infants and the blood group classification of mother and child in the ABO system].
Mozalevskiĭ AF
Pediatr Akus Ginekol; 1977; (1):22-4. PubMed ID: 882291
[No Abstract] [Full Text] [Related]
12. [Evaluation of the passage of the fetal cells into the maternal blood after pregnancy interruption in the light of data on autoimmunization in the ABO system].
Pertyński T; Torbus B; Krawczyk B
Pol Tyg Lek; 1967 Aug; 22(34):1277-80. PubMed ID: 6078713
[No Abstract] [Full Text] [Related]
13. [Spontaneous changes in the growth hormone and insulin level in newborn infants].
Fekete M; Milner RD
Orv Hetil; 1975 Mar; 116(10):549-52. PubMed ID: 803671
[No Abstract] [Full Text] [Related]
14. [The development of immunologic factors in children with hyperbilirubinemia].
Nejedlá Z
Monatsschr Kinderheilkd (1902); 1968 Nov; 116(11):574-6. PubMed ID: 4890945
[No Abstract] [Full Text] [Related]
15. [Medicamentous prevention of hyperbilirubinemia in newborn infants. VII. Development of a screening test for the early diagnosis of hyperbilirubinemia using multi-dimensional analysis of variance and discriminant analysis].
Gmyrek D; Läuter J; Cario WR; Syllm-Rapoport I
Dtsch Gesundheitsw; 1973 Jan; 28(2):88-96. PubMed ID: 4724673
[No Abstract] [Full Text] [Related]
16. [Neonatal hyperbilirubinemia. Its relation to the immunological response capacity of the newborn infant].
Díaz del Casrillo E
Gac Med Mex; 1973 Feb; 105(2):185-207. PubMed ID: 4732589
[No Abstract] [Full Text] [Related]
17. [THE DEVELOPMENT OF THROMBOCYTE COUNT FOLLOWING EXCHANGE TRANSFUSION IN INFANCY].
DUX E; KOVACS Z; PATAKI L
Orv Hetil; 1963 Sep; 104():1641-5. PubMed ID: 14054562
[No Abstract] [Full Text] [Related]
18. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
[TBL] [Abstract][Full Text] [Related]
19. Failure to predict hemolysis and hyperbilirubinemia by IgG subclass in blood group A or B infants born to group O mothers.
Kaplan M; Na'amad M; Kenan A; Rudensky B; Hammerman C; Vreman HJ; Wong RJ; Stevenson DK
Pediatrics; 2009 Jan; 123(1):e132-7. PubMed ID: 19114458
[TBL] [Abstract][Full Text] [Related]
20. [Manner, formation of hazardous antibodies for pregnancy].
Aufeuvre JP
Soins Gynecol Obstet Pueric Pediatr; 1983; (27-28):7-10. PubMed ID: 6558884
[No Abstract] [Full Text] [Related]
[Next] [New Search]
